Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Carolyn E. TaylorDirector | Tonix Pharmaceuticals HoldingTNXP | Open-market buy | 06/12 | 06/15 | 1,415 sh | $10.55 | $14,928.25 | +338.5% |
Tonix Pharmaceuticals HoldingTNXP | Open-market buy | 06/09 | 06/09 | 5,000 sh | $11.79 | $58,950 | +124.8% | |
Richard Newcomb StillwellDirector | Tonix Pharmaceuticals HoldingTNXP | Open-market buy | 06/08 | 06/09 | 5,000 sh | $11.65 | $58,250 | No record |
Tonix Pharmaceuticals HoldingTNXP | Open-market buy | 03/31 | 04/01 | 5,000 sh | $12.62 | $63,100 | +33.3% | |
Tonix Pharmaceuticals HoldingTNXP | Open-market buy | 03/18 | 03/18 | 15,000 sh | $14.89 | $223,350 | +1500000.0% | |
Carolyn E. TaylorDirector | Tonix Pharmaceuticals HoldingTNXP | Open-market buy | 25/08/21 | 25/08/21 | 418 sh | $36.03 | $15,060.54 | No record |
James TrecoDirector | Tonix Pharmaceuticals HoldingTNXP | Open-market buy | 25/08/20 | 25/08/20 | 250 sh | $36.00 | $9,000 | No record |
Tonix Pharmaceuticals HoldingTNXP | Open-market buy | 25/05/15 | 25/05/15 | 4,000 sh | $21.55 | $86,200 | +80000.0% |